U.S. market Closed. Opens in 17 hours 10 minutes

TSVT | 2seventy bio, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-31
Revenue100.39M91.50M54.52M248.12M44.30M54.58M
Cost of Revenue27.20M26.22M12.59M5.40M2.98M885.00K
Gross Profit73.18M65.28M41.93M242.73M41.32M53.69M
Operating Expenses289.89M328.19M355.44M387.36M379.29M254.12M
Selling, General & Admin69.41M79.45M93.51M90.90M81.65M53.63M
Research & Development220.47M248.74M261.94M296.47M297.64M200.49M
Other Operating Expenses7.62M6.05M21.65M18.06M20.13M19.16M
Operating Income-216.70M-262.91M-313.51M-144.64M-337.97M-203.43M
Other Expenses / Income-867.00K8.76M21.30M24.52M17.38M16.16M
Before Tax Income-217.57M-254.15M-292.21M-120.11M-320.59M-199.75M
Income Tax Expenses10.12M-8.99K-16.00M18.06M2.75M19.16M
Net Income-217.57M-254.14M-276.21M-138.17M-323.34M-199.75M
Interest ExpensesN/A-8.51MN/AN/AN/A15.49M
Basic Shares Outstanding49.28M35.64M23.59M23.29M23.29M23.29M
Diluted Shares Outstanding49.28M35.64M23.59M23.29M23.29M23.29M
EBITDA-206.42M-251.14M-313.07M-113.39M-322.64M-167.92M
EBITDA Margin-205.62%-274.49%-574.21%-45.70%-728.37%-307.66%
EBIT-207.45M-262.67M-292.21M-120.11M-320.59M-165.10M
EBIT Margin-206.65%-287.08%-535.95%-48.41%-723.75%-302.50%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙